Seed Health Stock
| Valuation | $175M1, 2 |
| Valuation Date | Apr 21, 2021 |
| Implied Valuation | n/a |
| Last Price | $9.00 |
| 52-Week High | $9.00 |
| 52-Week Low | $9.00 |
| YTD Return | +0.00% |
| 1-Year Return | +0.00% |
| 3-Year Return | n/a |
| Total Funding | $43.8M1 |
| Latest Round Amount | $40M3 |
| Latest Round | Series A |
| Funding Rounds | 3 |
| IPO Status | Unknown |
| Expected IPO Date | n/a |
| Revenue | $200M4 |
| Revenue Type | 2024 |
| P/S Ratio | 0.9 |
About Seed Health
Seed Health is a microbiome science company that develops and sells clinically studied probiotic and supplement products under the Seed brand. Its flagship product is the DS-01 Daily Synbiotic, a capsule-in-capsule formulation that pairs 24 probiotic strains with a polyphenol prebiotic, and the line has since grown to include a pediatric synbiotic, the VS-01 vaginal synbiotic and a Co-Biotics range covering daily nutrition, energy and sleep. Seed Health makes money by selling these supplements on a monthly subscription through seed.com and Amazon, and through retail partners including Target and Sprouts Farmers Market. The company also runs SeedLabs, an environmental research division that studies microbial applications for problems such as coral reef decline and soil contamination.
Invest in Seed Health
Seed Health is a private company, so you can't purchase it with a regular brokerage account. However, its shares are available on Hiive.
Hiive is a secondary marketplace where accredited investors can buy and sell shares of private, pre-IPO companies. Invest in the world's most exciting startups before they go public.
Invest on HiiveStock Analysis may be compensated for user sign-ups through Hiive links. Hiive is not affiliated with Stock Analysis. Securities offered by Hiive Markets Limited, member of FINRA/SIPC.
News
New Data Show Seed's Co-Biotics Increase Bioactive Vitamin B3, Gut-Brain Metabolites, and Sleep-Related Tryptophan Through the Microbiome
Seed Health presented three preclinical studies at NUTRITION 2026 testing its DM-02, AM-02 and PM-02 Co-Biotic formulations in an ex vivo model of the human gut. The studies reported increases in bioa...
Seed Health Appoints Anisha Raghavan as First-Ever Chief Marketing Officer to Lead Next Chapter of Brand Growth
Seed Health named Anisha Raghavan as its first chief marketing officer, giving her responsibility for brand, growth, creative and commercial strategy. The company said the appointment follows expansio...
Seed Health and The Two Frontiers Project Launch Initiative to Explore Microbial Solutions to "Forever Chemicals"
Seed Health's SeedLabs division and The Two Frontiers Project launched The Resilient Soils Project, a community science effort that collects soil samples from contaminated sites for metagenomic sequen...
New Clinical Trial Shows Seed's DS-01 Reduces Bloating, Improves Regularity, and Enhances Digestive Quality of Life
Seed Health announced the publication in Nutrients of a randomized, placebo-controlled trial of its DS-01 Daily Synbiotic in healthy adults. The company said the study found reductions in bloating, ga...
Seed Redefines Daily Supplementation With the Launch of Co-Biotics -- A New Category of Targeted Innovations for the Body and Microbiome
Seed launched three Co-Biotic products, the DM-02 Daily Multivitamin, AM-02 Energy + Focus and PM-02 Sleep + Restore, expanding the company beyond its synbiotic line. The products went on sale on Seed...
Seed expands portfolio with Co-Biotics line for sleep, energy and daily nutrition
NutraIngredients interviewed chief executive Cathrin Bowtell about the Co-Biotics launch and the company's pricing and channel plans. Bowtell said Seed avoids SKU proliferation and set omnichannel pri...
As Coral Reefs Vanish, Scientists Are Turning to Aquariums for Help
SeedLabs, Seed Health's environmental research division, described work with aquariums to study microbial approaches to coral reef conservation. The effort is part of the company's research into micro...
Leading Gut Health Company Seed Expands Retail Footprint with Nationwide Launch at Sprouts Farmers Market
Seed launched DS-01 Daily Synbiotic and DS-01 14 Day Gut Reset at all 450 Sprouts stores across 24 states, expanding its omnichannel retail footprint.
EXCLUSIVE: Seed Health's New CEO Cathrin Bowtell Discusses Sprouts Launch and What's Next for the Microbiome Company
In her first interview as chief executive, Cathrin Bowtell discussed Seed's rollout into 450 Sprouts stores and the plans behind the leadership handover from co-founders Ara Katz and Raja Dhir. Source...
Seed Health Presents New Clinical Trial Data: DS-01 Increases Two Key Microbiome Molecules Linked to Gut, Metabolic, Immune, and Cellular Health
Seed Health presented clinical trial data on its DS-01 Daily Synbiotic and two microbiome-derived molecules linked to gut, metabolic, immune and cellular health. The results extend the company's clini...
Leading Microbiome Brand Seed Launches Award-Winning Probiotics in Target Stores Nationwide
Seed brought its DS-01 Daily Synbiotic and PDS-08 Pediatric Daily Synbiotic to every Target store and Target.com, its first move into mass retail. The launch included a Target-exclusive product, the D...
Probiotics maker Seed Health explores $1 billion sale, sources say
Reuters reported that Seed Health's owners were soliciting acquisition offers with advice from Centerview in a process that could value the company above $1 billion. The report said Seed expected arou...
Seed Health Launches VS-01, a First-of-Its-Kind Vaginal Microbiome Innovation to Redefine Vaginal Care
Seed Health introduced VS-01, a vaginal synbiotic suppository, marking the company's entry into women's health. The product extends its microbiome portfolio beyond the gut.
Seed Health Appoints Microbiome Pioneer Zain Kassam, M.D., M.P.H. as Chief Medical Officer
Seed Health named gastroenterologist and microbiome researcher Zain Kassam as chief medical officer. Kassam oversees the company's clinical research programs.
Seed Health and The Two Frontiers Project Join Forces to Tap Extreme Microbes for Novel Solutions to the Climate Crisis
Seed Health and The Two Frontiers Project began a joint effort to collect and study microbes from extreme environments for climate applications. The work is run through the company's SeedLabs division...
Seed Health Launches Computational Biology Platform Powered by Most Comprehensive Host-Microbiome Data Set to Expand Pipeline Beyond the Gut
Seed Health launched a computational biology platform built on a large host-microbiome data set to support product development outside the gut. The company said the platform underpins its pipeline acr...